Cargando…
Microfluidic chip-based technologies: emerging platforms for cancer diagnosis
The development of early and personalized diagnostic protocols is considered the most promising avenue to decrease mortality from cancer and improve outcome. The emerging microfluidic-based analyzing platforms hold high promises to fulfill high-throughput and high-precision screening with reduced eq...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849190/ https://www.ncbi.nlm.nih.gov/pubmed/24070124 http://dx.doi.org/10.1186/1472-6750-13-76 |